Product Description
| Cat Number | KS-260 |
|---|---|
| Category | Peptide |
| Pack Size | 5 mg |
| Description | GSK3 inhibitor |
| Purity | 99% by TLC, NMR conforms |
| Biomarker Target | Kinases |
| Sequence Three Letter Code | 6-[[2-[[4-(2,4-Dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]ethyl]amino]-3-pyridinecarbonitrile |
| Molecular Formula | C22H18Cl2N8 |
| Solubility | Soluble in DMSO to 25 mg/ml |
| Appearance | White solid |
| Storage | Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 3 months. |
| References |
Ring (2003) Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo. Diabetes 52(3) 588 PMID: 12606497Seong et al (2022) Epiblast inducers capture mouse trophectoderm stem cells in vitro and pattern blastoids for implantation in utero. Cell Stem Cell 29(7) 1102 PMID: 35803228Schafer et al (2023) An in vivo neuroimmune organoid model to study human microglia phenotypes. 186(10) 2111 PMID: 37172564 Related areasAll small molecules >All kinase modulators >All stem cell research categories > |
| Note | The product is for research use only |
Share Item: